Cargando…

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection

Effective therapies are urgently needed for the SARS-CoV-2/COVID-19 pandemic. We identified panels of fully human monoclonal antibodies (mAbs) from large phage-displayed Fab, scFv, and VH libraries by panning against the receptor binding domain (RBD) of the SARS-CoV-2 spike (S) glycoprotein. A high-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Chen, Chuan, Drelich, Aleksandra, Martinez, David R., Gralinski, Lisa E., Sun, Zehua, Schäfer, Alexandra, Kulkarni, Swarali S., Liu, Xianglei, Leist, Sarah R., Zhelev, Doncho V., Zhang, Liyong, Kim, Ye-Jin, Peterson, Eric C., Conard, Alex, Mellors, John W., Tseng, Chien-Te K., Falzarano, Darryl, Baric, Ralph S., Dimitrov, Dimiter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2020
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703590/ https://www.ncbi.nlm.nih.gov/pubmed/33139569 http://dx.doi.org/10.1073/pnas.2010197117

Ejemplares similares

High Potency of a Bivalent Human V(H) Domain in SARS-CoV-2 Animal Models
por: Li, Wei, et al.
Publicado: (2020)

Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody
por: Liu, Xianglei, et al.
Publicado: (2021)

Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
por: Sun, Zehua, et al.
Publicado: (2020)

Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020)

Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
por: Kim, Ye-Jin, et al.
Publicado: (2023)

Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization
por: Buongervino, Samantha, et al.
Publicado: (2021)

Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22
por: Sun, Zehua, et al.
Publicado: (2022)

Protocol for constructing large size human antibody heavy chain variable domain (V(H)) library and selection of SARS-CoV-2 neutralizing antibody domains
por: Chen, Chuan, et al.
Publicado: (2021)

Molecular pathology of emerging coronavirus infections
por: Gralinski, Lisa E, et al.
Publicado: (2015)

Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections
por: Leist, Sarah R., et al.
Publicado: (2018)

Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases
por: Chu, Xiaojie, et al.
Publicado: (2021)

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
por: Gralinski, Lisa E., et al.
Publicado: (2018)

GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
por: Pascual-Pasto, Guillem, et al.
Publicado: (2022)

New Metrics for Evaluating Viral Respiratory Pathogenesis
por: Menachery, Vineet D., et al.
Publicado: (2015)

Modeling pathogenesis of emergent and pre-emergent human coronaviruses in mice
por: Cockrell, Adam S., et al.
Publicado: (2018)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Human Antibody V(H) Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for Cancers
por: Chu, Xiaojie, et al.
Publicado: (2023)

Human antibody V(H) domains targeting uPAR as candidate therapeutics for cancers
por: Chu, Xiaojie, et al.
Publicado: (2023)

Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysis
por: Leist, Sarah R., et al.
Publicado: (2019)

Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
por: Chen, Chuan, et al.
Publicado: (2022)

Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
por: Chen, Chuan, et al.
Publicado: (2022)

Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
por: Sun, Zehua, et al.
Publicado: (2023)

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection
por: Graham, Jessica B., et al.
Publicado: (2020)

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice
por: Graham, Jessica B., et al.
Publicado: (2021)

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope
por: Raman, Swetha, et al.
Publicado: (2021)

Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
por: van Doremalen, Neeltje, et al.
Publicado: (2017)

Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET Agents
por: Sun, Zehua, et al.
Publicado: (2023)

Epigenetic Landscape during Coronavirus Infection
por: Schäfer, Alexandra, et al.
Publicado: (2017)

Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
por: Geng, Qibin, et al.
Publicado: (2021)

The Secret Life of ACE2 as a Receptor for the SARS Virus
por: Dimitrov, Dimiter S
Publicado: (2003)

Virus entry: molecular mechanisms and biomedical applications
por: Dimitrov, Dimiter S.
Publicado: (2004)

Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008)

Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

Current healthcare in Bulgaria: time for predictive diagnostics and preventive medicine
por: Dimitrov, Dimiter V.
Publicado: (2010)

Systems patientomics: the virtual in-silico patient
por: Dimitrov, Dimiter V
Publicado: (2014)

Systems approaches to computational modeling of the oral microbiome
por: Dimitrov, Dimiter V.
Publicado: (2013)

Medical Internet of Things and Big Data in Healthcare
por: Dimitrov, Dimiter V.
Publicado: (2016)

Blockchain Applications for Healthcare Data Management
por: Dimitrov, Dimiter V.
Publicado: (2019)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_alpmd9l84jou4uuq22p3nmjhte